AAAAAA
Results:
1-8
|
Results: 8
Authors:
Larson, AM
Citation: Am. Larson, Retreatment of hepatitis C: Interferon nonresponders, GASTR HEPAT, 8, 2002, pp. 233-261
Authors:
Larson, AM
Carithers, RL
Citation: Am. Larson et Rl. Carithers, Hepatitis C in clinical practice, J INTERN M, 249(2), 2001, pp. 111-120
Authors:
Carr, DB
Larson, AM
Schmucker, BC
Brateng, DA
Carithers, RL
Easterling, TR
Citation: Db. Carr et al., Maternal hemodynamics and pregnancy outcome in women with prior orthotopicliver transplantation, LIVER TRANS, 6(2), 2000, pp. 213-221
Authors:
Cotler, SJ
Wartelle, CF
Larson, AM
Gretch, DR
Jensen, DM
Carithers, RL
Citation: Sj. Cotler et al., Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C, J VIRAL HEP, 7(3), 2000, pp. 211-217
Authors:
Nousbaum, JB
Polyak, SJ
Ray, SC
Sullivan, DG
Larson, AM
Carithers, RL
Gretch, DR
Citation: Jb. Nousbaum et al., Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy, J VIROLOGY, 74(19), 2000, pp. 9028-9038
Authors:
Dwight, MM
Kowdley, KV
Russo, JE
Ciechanowski, PS
Larson, AM
Katon, WJ
Citation: Mm. Dwight et al., Depression, fatigue, and functional disability in patients with chronic hepatitis C, J PSYCHOSOM, 49(5), 2000, pp. 311-317
Authors:
Polyak, SJ
Nousbaum, JB
Larson, AM
Cotler, S
Carithers, RL
Gretch, DR
Citation: Sj. Polyak et al., The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon, J INFEC DIS, 182(2), 2000, pp. 397-404
Authors:
Larson, AM
Carithers, RL
Citation: Am. Larson et Rl. Carithers, Management of alcoholic liver disease, CLIN G MED, 1999, pp. 181-198
Risultati:
1-8
|